All

Trinity Biotech and University at Buffalo Partner to Commercialize Sjögren’s Syndrome Biomarkers

The collaboration focuses on advancing proprietary biomarkers for the earlier and more accurate detection of the autoimmune disease.

All

Largest Lung Nodule Biomarker Validation Study Backs Earlier Cancer Detection

A pooled analysis of more than 1,100 patients across four cohort studies supports the clinical utility of the Nodify CDT test in identifying high-risk lung nodules.

ADDF Launches Third Phase of Diagnostics Accelerator with $50 Million to Advance Alzheimer’s Blood Tests and AI Biomarkers
Siemens Healthineers Expands Brain Health Research Portfolio with New Blood-Based Tau Assays
Roche Receives CE Mark for Blood-Based Immunoassay Test to Detect Alzheimer’s Genetic Risk Factor ApoE4
NIH Awards $2.5 Million to Advance Eye-Based Detection of ALS Biomarker TDP-43
Blood Test for Endometriosis Detection Validated in Multi-Center Clinical Study
Deep Learning Pathology Models Caught ‘Cheating,’ Study Finds

All

Fecal DNA Methylation Test Shows Promise for Colorectal Cancer Screening

A multicenter study reports that combining fecal SDC2 methylation testing with the APCS scoring system improves advanced adenoma detection and specificity in colorectal cancer screening.

Blood Test Identifies Lung Cancer Patients Who Will Respond to Immunotherapy

Jan 27, 2026 | Lung Cancer

Researchers at Mass General Brigham have developed a blood test that predicts tarlatamab response in small cell lung cancer, showing 85% sensitivity and 100% specificity.

Researchers Identify Four New Markers for Detecting Aggressive Breast Cancer Cells in Blood

Jan 23, 2026 | Breast

Researchers at Baylor College of Medicine have identified four new protein markers that improve detection of triple-negative breast cancer cells in blood, potentially enhancing the accuracy of liquid biopsy tests, according to a recent study.

Finger Prick Blood Test for Alzheimer’s Diagnosis Enters Large-Scale Trial

Jan 20, 2026 | Dementias & Alzheimer’s

A large-scale international trial is evaluating a finger prick blood test for Alzheimer’s, analyzing three protein biomarkers as a potential alternative to PET scans and lumbar punctures.

New Blood Test Signature Could Improve Type 2 Diabetes Risk Prediction

Jan 14, 2026 | Diabetes & Metabolic Diseases, Diagnostic Technologies, Mass Spectrometry

A 44-metabolite blood test signature identified by Mass General Brigham and Einstein researchers improved type 2 diabetes risk prediction in a study of over 23,000 participants, according to Nature Medicine.

What Clinical Lab Leaders Predict for 2026

Dec 17, 2025 | Diagnostic Technologies

AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.

Neurogen Biomarking Partners with Tasso for Needle-Free Blood Collection in Alzheimer’s Testing

Nov 25, 2025 | Dementias & Alzheimer’s

The collaboration aims to make home-based Alzheimer’s biomarker testing more accessible through virtually painless blood collection technology.

New FDA-Cleared Blood Test Moves Alzheimer’s Assessment into Primary Care

Oct 28, 2025 | Dementias & Alzheimer’s

Roche’s Elecsys pTau181 assay gives clinical labs a key role in the initial evaluation of cognitive decline, helping to rule out amyloid pathology earlier in the diagnostic process.

Study Demonstrates Accuracy of Two Quest Blood Tests for Alzheimer’s Diagnosis

Oct 27, 2025 | Dementias & Alzheimer’s

Two biomarker panels demonstrated 91% sensitivity and specificity in symptomatic patients, potentially reducing the need for PET imaging confirmation.

AI Platform Adds Nutrition Integration to Lab Result Interpretation

Oct 2, 2025 | Middleware & Software

BloodGPT’s new feature provides biomarker-based nutrition plans alongside automated lab result analysis for clinical laboratories.

Lunit and Agilent Partner to Develop AI-Powered Companion Diagnostics

Sep 24, 2025 | Molecular Diagnostic Analyzers

The collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.

Korean Researchers Develop SERS Platform 100,000 Times More Sensitive Than ELISA for Alzheimer’s Detection

Aug 18, 2025 | Dementias & Alzheimer’s

The surface-enhanced Raman spectroscopy platform can detect amyloid beta biomarkers at ultra-low concentrations in body fluids, potentially enabling earlier diagnosis and monitoring of disease progression.

Roche Shares Alzheimer’s Drug and Diagnostic Advances at AAIC 2025

Jul 28, 2025 | Dementias & Alzheimer’s

At the Alzheimer’s Association International Conference, Roche shared new data on its investigational antibody trontinemab and its Elecsys pTau217 blood test.